Department of Oncology, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.
Health Services Research Unit, Lillebaelt Hospital - University Hospital of Southern Denmark, Vejle, Denmark.
Scand J Caring Sci. 2022 Mar;36(1):81-89. doi: 10.1111/scs.12965. Epub 2021 Feb 19.
Patients with advanced cancer are faced with a wide variety of challenges and difficult treatment decisions made while in a vulnerable life-threatening situation, including decisions about clinical trial participation. Internationally, there is a great focus on shared decision-making as a way to help patients and healthcare professionals to make informed decisions together; nevertheless, research focusing on patient experiences shows that information about clinical trials is insufficient in supporting patients to make trial decisions in the context of their course of disease and managing life with advanced cancer.
To explore where and how decisions about participation in oncology clinical trials are made and the role of the patients and healthcare professionals.
Participant observation was used as a qualitative research method to gain knowledge about decision-making in different clinical situations. Data were analysed using thematic analysis.
Four themes were developed: (a) preformed decisions, (b) dissimilar perceptions of successful treatment, (c) cues and concerns stated by patients and (d) creating common ground.
There are underexposed aspects to be aware of in the decision-making process for clinical trial participation. Preformed decisions made by the physicians before the encounter with patients seemed to narrow down the patients' options and could have benefited from including the patients' views. Cues and concerns stated by patients were often neglected. However, when physicians talked with the patients about truly difficult issues such as treatment expectations, hope and death, it led to another kind of conversation about treatment decisions involving the patients' preferences.
Awareness of preformed decisions and an increased focus on picking up cues and concerns about existential issues in the clinical encounter may improve the quality of the decisions and increase shared decision-making.
晚期癌症患者面临着各种各样的挑战和艰难的治疗决策,这些决策是在危及生命的脆弱情况下做出的,包括参与临床试验的决策。在国际上,人们非常关注共同决策,认为这是帮助患者和医疗保健专业人员共同做出明智决策的一种方式;然而,关注患者体验的研究表明,关于临床试验的信息不足以支持患者在疾病过程和管理晚期癌症的生活中做出试验决策。
探讨参与肿瘤学临床试验的决策在哪里以及如何做出,以及患者和医疗保健专业人员的作用。
采用参与者观察作为一种定性研究方法,以了解不同临床情况下的决策过程。使用主题分析对数据进行分析。
确定了四个主题:(a)预先做出的决定,(b)对成功治疗的不同看法,(c)患者提出的线索和关注点,以及(d)建立共同点。
在参与临床试验的决策过程中有一些未被充分认识的方面。医生在与患者接触之前做出的预先决定似乎限制了患者的选择,并且如果包括患者的观点,可能会受益。患者提出的线索和关注点往往被忽视。然而,当医生与患者谈论真正困难的问题,如治疗期望、希望和死亡时,这会导致另一种涉及患者偏好的治疗决策对话。
意识到预先做出的决定,并更加关注在临床接触中发现与存在有关的问题的线索和关注点,可能会提高决策的质量,并增加共同决策。